Whole exome sequencing for cancer - is there evidence of clinical utility?

Background: In recent years, whole exome sequencing (WES), which allows detection of 85% of disease-causing variants, has been used to compare tumor and normal DNA to allow the identification of variants specific to the tumor. Genetic changes in cancer are increasingly used for diagnosis and may gui...

Ausführliche Beschreibung